Brief: Cystic Fibrosis Foundation Makes Equity Investment In Armata Pharmaceuticals
28/10/2021 23:48
Oct 28 (Reuters) - Armata Pharmaceuticals Inc ARMP.A :
* CYSTIC FIBROSIS FOUNDATION MAKES EQUITY INVESTMENT IN
ARMATA
PHARMACEUTICALS
* CF FOUNDATION HAS ELECTED TO MAKE A $3.0 MILLION EQUITY
INVESTMENT IN COMMON STOCK OF ARMATA
* INNOVIVA, A SIGNIFICANT ARMATA SHAREHOLDER, HAS ALSO
ELECTED TO
INVEST $4.0 MILLION AT SAME TERMS
Source text for Eikon: ID:nPn4lQTdsa
Further company coverage: ARMP.A
((reuters.briefs@thomsonreuters.com;))
Recent news on Armata Pharmaceuticals
See all newsBrief: Armata Pharmaceuticals Announces First Quarter 2026 Results And Provides Corporate Update
Brief: Armata Pharmaceuticals Delays Announcement Of Fourth Quarter And Full-Year 2025 Results And Provides Corporate Update
Brief: Armata Pharmaceuticals Receives FDA Qualified Infectious Disease Product Designation
Armata Pharma jumps on US FDA nod for late-stage infection trial
Brief: Armata Pharmaceuticals Commissions cGMP Manufacturing Facility In Los Angeles